Patient was hydrated and had CXR, which was normal, and a V/Q scan which did not show evidence for pulmonary embolism.
Physical Exam: Vitals- Tm 98.7, Tc 98.3, HR 71-87, BP 113-122/55-69 without pulses paradoxus, RR 20-27, 97% ra HEENT: Oropharynx non-erythematous; ear canals clear, TMs non-erythematous.
Tender to palpation in right upper quadrant.
Pertinent Results: [**2122-8-21**] 09:46PM   CREAT-3.8* POTASSIUM-5.0 [**2122-8-21**] 09:46PM   CALCIUM-8.1* PHOSPHATE-5.2* MAGNESIUM-2.1 [**2122-8-21**] 09:46PM   HCT-21.3* [**2122-8-21**] 08:44PM URINE  HOURS-RANDOM CREAT-81 SODIUM-88 [**2122-8-21**] 08:44PM URINE  COLOR-Yellow APPEAR-Clear SP [**Last Name (un) 155**]-1.015 [**2122-8-21**] 08:44PM URINE  BLOOD-LGE NITRITE-NEG PROTEIN-100 GLUCOSE-TR KETONE-NEG BILIRUBIN-NEG UROBILNGN-NEG PH-5.0 LEUK-NEG [**2122-8-21**] 08:44PM URINE  EOS-POSITIVE [**2122-8-21**] 04:10PM   GLUCOSE-84 UREA N-52* CREAT-3.7* SODIUM-137 POTASSIUM-5.4* CHLORIDE-109* TOTAL CO2-19* ANION GAP-14 [**2122-8-21**] 04:10PM   ALT(SGPT)-24 AST(SGOT)-21 CK(CPK)-44 ALK PHOS-113 TOT BILI-0.2 [**2122-8-21**] 04:10PM   CK-MB-1 cTropnT-<0.01 [**2122-8-21**] 04:10PM   calTIBC-243* VIT B12-262 FERRITIN-156* TRF-187* [**2122-8-21**] 04:10PM   C3-119 C4-34 [**2122-8-21**] 04:10PM   WBC-4.9 RBC-2.48* HGB-6.8* HCT-20.7* MCV-84 MCH-27.4 MCHC-32.7 RDW-12.1 [**2122-8-21**] 04:10PM   PLT COUNT-196 [**2122-8-21**] 06:41AM   CK-MB-NotDone cTropnT-<0.01 [**2122-8-21**] 06:41AM   HAPTOGLOB-201* [**2122-8-21**] 06:41AM   ASA-NEG ETHANOL-NEG ACETMNPHN-NEG bnzodzpn-NEG barbitrt-NEG tricyclic-NEG [**2122-8-21**] 06:41AM   WBC-4.8 RBC-2.38* HGB-6.5* HCT-19.9* MCV-84 MCH-27.4 MCHC-32.8 RDW-12.2 [**2122-8-21**] 06:41AM   PLT COUNT-201 [**2122-8-21**] 04:00AM URINE  HOURS-RANDOM CREAT-95 SODIUM-33 POTASSIUM-59 [**2122-8-21**] 04:00AM URINE  OSMOLAL-386 [**2122-8-21**] 04:00AM URINE  bnzodzpn-NEG barbitrt-NEG opiates-NEG cocaine-NEG amphetmn-NEG mthdone-NEG [**2122-8-21**] 04:00AM URINE  COLOR-Straw APPEAR-Hazy SP [**Last Name (un) 155**]-1.014 [**2122-8-21**] 04:00AM URINE  BLOOD-LG NITRITE-NEG PROTEIN-100 GLUCOSE-NEG KETONE-TR BILIRUBIN-NEG UROBILNGN-NEG PH-5.0 LEUK-NEG [**2122-8-21**] 04:00AM URINE  GRANULAR-[**4-11**]* [**2122-8-21**] 01:45AM   AMYLASE-72 [**2122-8-21**] 01:45AM   LIPASE-25 [**2122-8-21**] 01:45AM   VIT B12-261 FOLATE-10.8 [**2122-8-21**] 01:30AM   GLUCOSE-95 UREA N-61* CREAT-4.2* SODIUM-133 POTASSIUM-5.4* CHLORIDE-104 TOTAL CO2-20* ANION GAP-14 [**2122-8-21**] 01:30AM   LD(LDH)-146 AMYLASE-74 TOT BILI-0.1 DIR BILI-<0.1 [**2122-8-21**] 01:30AM   TSH-9.9* [**2122-8-21**] 01:30AM   T4-6.6 [**2122-8-21**] 01:30AM   NEUTS-61.6 LYMPHS-28.5 MONOS-5.8 EOS-3.9 BASOS-0.2 [**2122-8-21**] 01:30AM   PLT COUNT-206 [**2122-8-21**] 01:30AM   D-DIMER-3397* [**2122-8-21**] 01:30AM   RET AUT-0.6*  Brief Hospital Course: 1.
Urinalysis showed nephritic range proteinuria, red cells, white cells, and red cell casts.
On admission, BUN was 61, creatinine was 4.2.
Anti-glomerular basement membrane antibodies returned at 19 (positive is >3) and ANCA was positive.
Renal biopsy was performed [**8-24**] and confirmed glomerulonephritis.
Immunofluoresence staining showed IgG deposition in a crescentic pattern, confirming anti-GBM disease.
Central cathater was placed [**8-27**] and patient underwent plasmaphoresis [**8-27**], [**8-28**].
Renal function improved over her stay in house; creatinine trended downward from 4.2 on admission to 2.7 on discharge.
Pericarditis Transthoraic [**Hospital1 **] showed a small pericardial effusion witgh right ventricular diastolic collapse, consistent with impaired filling/tamponade.
Repeat transthoracic [**Month/Day (2) **] on [**8-24**] revealed a stable pericadial effusion.
Patient will follow up with a repeat transthoracic [**Month/Year (2) **] [**2122-9-10**].
Anemia On presentation, patient's hematocrit was 19.9.
Iron studies were consistent with an anemia of chronic inflammation.
Hematocrit trended upwards while patient was in house, and was 21.4 on discharge.
LFTs, RUQ u/s, and Hep B/C serologies unrevealing.
Calcium Carbonate 500 mg Tablet, Chewable Sig: Three (3) Tablet, Chewable PO TID w/ meals as needed: Calcium supplement.
Hematocrit improved from admission.
Followup Instructions: Cardiac: Provider: [**Name10 (NameIs) **] LAB TESTING Where: BA [**Hospital Unit Name **] ([**Hospital Ward Name **] COMPLEX) [**Hospital Ward Name **] LAB Phone:[**Telephone/Fax (1) 128**] Date/Time:[**2122-9-10**] 11:00 .
Provider: [**Name10 (NameIs) 1248**],BED FIVE [**Name10 (NameIs) 1248**] ROOMS Where: [**Name10 (NameIs) 1248**] ROOMS Date/Time:[**2122-8-31**] 2:15.
Phone: [**Telephone/Fax (1) 46376**] Provider: [**Name10 (NameIs) 1248**],BED FOUR [**Name10 (NameIs) 1248**] ROOMS Where: [**Name10 (NameIs) 1248**] ROOMS Date/Time:[**2122-9-2**] 9:15 Provider: [**Name10 (NameIs) 1248**],ISOLATION ROOM [**Name10 (NameIs) 1248**] ROOMS Where: [**Name10 (NameIs) 1248**] ROOMS Date/Time:[**2122-9-4**] 9:15                                [**Name6 (MD) 251**] [**Name8 (MD) **] MD [**MD Number(1) 910**]
